LENZ Therapeutics, Inc. (LENZ)

Corporate Overview

LENZ Therapeutics is a late clinical-stage company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Our Leadership

Latest Financial Results

Q2 2024

Quarter Ended Jun 30, 2024

Earnings Release PDF

Earnings Webcast

10-Q PDF

XBRL

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Latest News

Sep 30, 2024 • 8:00 AM EDT

LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences

View Press Release View All News

Upcoming Event

Oct 17, 2024 1:15 pm CDT

Eyecelerator at the 2024 American Academy of Ophthalmology (AAO) Annual Meeting

Add to Calendar View All Events

Email Alerts

Get the latest news and reports delivered right to your inbox.

IR Contacts

Corporate

LENZ Therapeutics, Inc.
201 Lomas Santa Fe Drive
Suite 300
Solana Beach, CA 92075
T: (888) 928-LENZ (5369)
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449